50% Dextrose Injection Shortage
Last Updated: April 28, 2025
Status: Current
Products Affected - Description
-
- 50% Dextrose intravenous injection, Pfizer, 50 mL LifeShield syringe, 10 count, NDC 00409-4902-34
- 50% Dextrose intravenous injection, Pfizer, 50 mL Ansyr II Luer Lock syringe, 10 count, NDC 00409-7517-16
Reason for the Shortage
-
- Amphastar has 50% dextrose injection available.
- Pfizer has 50% dextrose on shortage due to manufacturing delays.
Available Products
-
- 50% Dextrose intravenous injection, Amphastar, 50 mL Luer-Jet syringe, 10 count, NDC 76329-3302-01
- 50% Dextrose intravenous injection, Pfizer, 50 mL vial, 25 count, NDC 00409-6648-02
Estimated Resupply Dates
-
- Pfizer has 50% dextrose 50 mL LifeShield syringes on back order and the company estimates a release date of September 2025. The 50 mL Ansyr II syringes are available in limited supply with weekly releases.
Updated
Updated April 28, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.